Recombinant Saccharomyces cerevisiae T-complex protein 1 subunit delta (CCT4)

What is the T-complex protein 1 subunit delta (CCT4) in S. cerevisiae?

CCT4 is one of eight paralogous subunits (CCT1-CCT8) that form the eukaryotic chaperonin complex known as TRiC (TCP-1 Ring Complex) or CCT (Chaperonin Containing TCP1). In S. cerevisiae, this essential complex forms a double-ring structure with each ring containing eight different CCT subunits arranged in a specific order. The complex assists in the proper folding of approximately 10% of newly synthesized proteins, including critical cytoskeletal proteins like actin and tubulin, in an ATP-dependent manner .

How does CCT4 function within the TRiC chaperonin complex?

CCT4 functions as an integral component of the TRiC complex, which encapsulates substrate proteins within its central cavity to facilitate their folding. The complex undergoes conformational changes driven by ATP binding and hydrolysis, creating a protected environment for protein folding. Each CCT subunit, including CCT4, contributes to ATP hydrolysis and substrate recognition, although they may have distinct substrate preferences and ATP hydrolysis rates . The chaperonin interacts with and mediates the correct folding of numerous proteins, including translation initiation factors .

What is the molecular structure of CCT4?

The CCT4 subunit contains three distinct domains: an equatorial domain housing the ATP-binding site, an intermediate domain, and an apical domain involved in substrate binding. When assembled in the TRiC complex, CCT4 occupies a specific position within the hetero-oligomeric ring. Interestingly, when expressed recombinantly in isolation, CCT4 can form homo-oligomeric complexes composed of 16 CCT4 subunits arranged in two back-to-back rings of 8 subunits each, resembling the native TRiC structure .

What are the optimal conditions for expressing recombinant S. cerevisiae CCT4?

For optimal expression of recombinant S. cerevisiae CCT4:

• Expression system: E. coli BL21(DE3) strains with T7 promoter-based vectors have been successfully used .

• Induction conditions: IPTG concentration of 0.5-1.0 mM at lower temperatures (16-20°C) for extended periods (12-16 hours) improves the yield of soluble protein.

• Media supplements: Addition of trace metals, particularly zinc ions, can enhance proper folding .

• Co-expression strategies: Co-expression with molecular chaperones can increase soluble protein yield.

• Strain considerations: Use of E. coli strains optimized for expression of eukaryotic proteins with rare codons may improve expression levels.

What purification strategies yield high-purity functional CCT4?

A multi-step purification approach typically yields the best results:

Throughout purification, maintaining buffers with ATP (1-5 mM) and magnesium (5-10 mM) is crucial for preserving the oligomeric state and chaperonin activity . Reducing agents (1-5 mM DTT or β-mercaptoethanol) should be included to prevent oxidation of cysteine residues.

How can researchers verify the proper folding and oligomerization of recombinant CCT4?

Multiple complementary techniques should be employed:

• Size exclusion chromatography to assess oligomeric state (properly assembled complexes elute at ~0.75-0.8 MDa)

• Sucrose gradient centrifugation (correctly formed complexes sediment at ~20S)

• Negative stain and cryo-electron microscopy to directly visualize complex formation

• ATPase activity assays to confirm functional activity

• Circular dichroism spectroscopy to verify secondary structure elements

• Luciferase refolding assays to assess chaperonin function

• Native PAGE to analyze complex formation

What imaging techniques are most effective for analyzing CCT4 structure?

For high-resolution structural analysis of recombinant CCT4 complexes:

How does the structure of homo-oligomeric CCT4 compare to its arrangement in the native TRiC complex?

Structural studies have revealed:

• Both homo-oligomeric CCT4 and native TRiC form double-ring structures with 8 subunits per ring

• Homo-oligomeric CCT4 forms back-to-back rings similar to TRiC

• The central cavity dimensions are comparable between both complexes

• The inter-subunit contacts in homo-oligomeric CCT4 are uniform, unlike in TRiC where contacts vary between different subunit pairs

• ATP binding sites in homo-oligomeric CCT4 are structurally equivalent, potentially leading to more synchronous ATP hydrolysis compared to TRiC

These structural similarities explain why homo-oligomeric CCT4 can perform chaperonin functions despite lacking the subunit diversity of TRiC .

What conformational changes occur in CCT4 during the ATP hydrolysis cycle?

During the ATP hydrolysis cycle, CCT4 undergoes significant conformational changes:

• ATP binding induces rotation of the intermediate domain, bringing catalytic residues closer to the nucleotide

• This conformational change transmits to the apical domain, causing it to move upward and inward

• These movements create a more enclosed central cavity for substrate folding

• After ATP hydrolysis, the complex transitions to a more open state

• Upon ADP release, the structure returns to its initial conformation

These ATP-dependent conformational changes create a cycle of substrate binding, encapsulation, folding, and release. In homo-oligomeric CCT4, these changes likely occur more synchronously than in the hetero-oligomeric TRiC complex .

What methods are most reliable for assessing CCT4 chaperonin activity?

The following assays provide robust measurement of chaperonin activity:

• Luciferase refolding assay:

  • Chemically or thermally denatured luciferase is incubated with CCT4

  • Refolding is quantified by measuring luminescence activity

  • Both CCT4 homo-oligomers and native TRiC can refold luciferase, making this a reliable comparative assay

• Prevention of protein aggregation:

  • Measured using light scattering or fluorescence of aggregation-sensitive dyes

  • Provides quantitative assessment of chaperonin protective function

  • Human γD-crystallin has been used successfully as a model substrate

• ATPase activity measurement:

  • Colorimetric assays (malachite green) to measure phosphate release

  • Coupled enzymatic assays to monitor ATP consumption

  • Provides information about the energy-consuming aspect of chaperonin function

• Substrate binding assays:

  • Co-immunoprecipitation or pull-down assays

  • Surface plasmon resonance to measure binding kinetics

  • Microscale thermophoresis for interaction analysis

How does the chaperonin activity of recombinant CCT4 homo-oligomers compare to native TRiC?

Comparative studies have revealed:

Despite these differences, CCT4 homo-oligomers maintain significant chaperonin activity, successfully assisting in refolding luciferase and suppressing the aggregation of substrates like human γD-crystallin .

What experimental design would best demonstrate ATP dependency of CCT4 chaperonin activity?

A comprehensive experimental design should include:

• Reaction conditions:

  • Complete system: CCT4 + substrate + ATP + Mg²⁺

  • No ATP control: CCT4 + substrate + Mg²⁺

  • Non-hydrolyzable ATP analog (AMP-PNP): CCT4 + substrate + AMP-PNP + Mg²⁺

  • ATPase-deficient CCT4 mutant: mutated CCT4 + substrate + ATP + Mg²⁺

• Measurement parameters:

  • Substrate folding (activity or fluorescence)

  • ATP hydrolysis (phosphate release)

  • Conformational changes (using labeled CCT4)

  • Complex formation (native PAGE or light scattering)

• Experimental variables:

  • ATP concentration range (0.1-10 mM)

  • Temperature (25-37°C)

  • Incubation time (0-120 minutes)

  • Substrate concentration

This multi-parameter approach would comprehensively characterize ATP dependency, differentiating between ATP binding and hydrolysis requirements for chaperonin function .

What are the critical controls required when studying recombinant CCT4 function?

Essential controls include:

• ATPase-deficient CCT4 mutant to confirm ATP dependency

• Heat-denatured CCT4 to distinguish specific chaperonin effects from non-specific effects

• Individual CCT4 monomers (not assembled into complexes) to confirm oligomerization requirement

• Native TRiC complex as a positive control for chaperonin activity

• Non-substrate proteins to confirm substrate specificity

• Reactions without ATP to demonstrate energy requirement

• Time zero measurements to establish baselines for activity assays

Including these controls ensures that observed effects can be confidently attributed to the chaperonin activity of CCT4 complexes rather than experimental artifacts.

How should researchers address potential artifacts when expressing S. cerevisiae CCT4 in heterologous systems?

When expressing S. cerevisiae CCT4 in systems like E. coli, researchers should address:

• Improper folding due to lack of yeast-specific factors:

  • Co-express with yeast chaperones

  • Use yeast-based expression systems for complex proteins

• Differences in post-translational modifications:

  • Verify modification status by mass spectrometry

  • Assess functional impact of modifications

• Formation of inclusion bodies:

  • Optimize expression conditions (temperature, inducer concentration)

  • Use solubility-enhancing tags

• Contamination with host chaperones:

  • Include stringent washing steps during purification

  • Verify purity by mass spectrometry

• Unwanted hetero-oligomeric interactions:

  • Perform analytical ultracentrifugation or native MS to confirm homogeneity

  • Use sucrose gradient centrifugation to isolate properly formed complexes

How do mutations in S. cerevisiae CCT4 affect TRiC assembly and function in vivo?

Mutations in CCT4 can have various effects on TRiC assembly and function:

• ATP-binding site mutations: The G345D mutation in CCT4 renders yeast temperature-sensitive for growth and abolishes ATP-induced allostery in the chaperonin complex

• Interface mutations can disrupt proper TRiC assembly

• Substrate-binding domain mutations may alter substrate specificity

• Point mutations in conserved residues can impact conformational changes necessary for chaperonin function

Research approaches to study these effects include:

• CRISPR-Cas9 genome editing for targeted mutations

• Complementation studies with mutant variants

• Temperature-sensitive mutants for conditional inactivation

• Proteomic analysis to assess global impacts on protein folding

What is the relationship between CCT4 oligomerization and its chaperonin activity?

Research into the relationship between oligomerization and activity has revealed:

• CCT4 can form functional homo-oligomeric complexes without other CCT subunits

• These homo-oligomers possess ATPase activity similar to the native TRiC complex

• The double-ring structure is essential for creating the central cavity where protein folding occurs

• Properly assembled CCT4 complexes can refold denatured luciferase and prevent protein aggregation

• The ability to form homo-oligomers is not universal among CCT subunits, with only CCT4 and CCT5 demonstrating this capability

This suggests that while the complete TRiC complex with all eight different subunits provides optimal function and substrate range, the basic chaperonin mechanism can be recapitulated by certain individual subunits, including CCT4.

How can single-molecule techniques advance our understanding of CCT4 function?

Single-molecule techniques offer unique insights into CCT4 function:

• Single-molecule FRET:

  • Label substrate proteins with FRET pairs

  • Directly observe folding trajectories of individual substrate molecules

  • Identify intermediate folding states

  • Measure conformational dynamics in real-time

• Optical tweezers:

  • Apply controlled forces to substrate proteins

  • Measure mechanical properties of chaperonin-substrate interactions

  • Determine force-dependent folding rates

• High-speed AFM:

  • Visualize conformational changes during ATP hydrolysis cycle

  • Observe substrate binding and release events

  • Characterize structural dynamics at nanoscale resolution

• Nanopore analysis:

  • Detect conformational states through ionic current measurements

  • Monitor protein translocation through the chaperonin

These techniques can reveal heterogeneity in folding pathways and kinetics that are masked in ensemble measurements, providing mechanistic insights into how CCT4 facilitates protein folding.

How conserved is CCT4 structure and function across different species?

Evolutionary analysis reveals:

• The CCT4 subunit is highly conserved from yeast to humans, reflecting its essential function

• Key functional domains show the highest sequence conservation:

  • ATP-binding pocket

  • Substrate-binding regions

  • Inter-subunit interfaces

• The human CCT4 gene shows significant homology to the S. cerevisiae counterpart

• Both human and yeast CCT4 can form functional homo-oligomeric complexes when expressed recombinantly

• The ability to form homo-oligomers suggests this may be an ancestral property of certain CCT subunits

This high degree of conservation facilitates comparative studies between species and allows insights from model organisms like S. cerevisiae to inform understanding of human CCT4 function.

What is the role of CCT4 in the context of other molecular chaperones in S. cerevisiae?

CCT4, as part of the TRiC complex, functions within a broader chaperone network:

• Hierarchical relationship:

  • Hsp70/Hsp40 chaperones often act upstream of TRiC

  • TRiC handles specific substrate classes that cannot be folded by simpler chaperone systems

• Cooperative interactions:

  • TRiC works with co-chaperones like prefoldin

  • Substrate transfer occurs between different chaperone systems

• Specialized roles:

  • TRiC has unique capability for folding certain cytoskeletal proteins

  • Other chaperones like Hsp90 focus on different substrate classes

Understanding these interactions is essential for dissecting the specific contribution of CCT4 to cellular proteostasis and identifying potential compensatory mechanisms in CCT4-deficient cells.

How can understanding of CCT4 function contribute to biotechnological applications?

Knowledge of CCT4 function can be leveraged for:

• Protein production enhancement:

  • Co-expression of CCT4 or engineered variants to improve folding of difficult-to-express proteins

  • Development of in vitro folding systems for complex proteins

• Enzyme stabilization:

  • Design of CCT4-based encapsulation systems to protect enzymes in industrial processes

  • Creation of artificial chaperonins with enhanced thermal stability

• Therapeutic development:

  • Targeting CCT4 interactions in diseases involving protein misfolding

  • Engineering CCT4-based delivery systems for protein therapeutics

• Synthetic biology applications:

  • Designing minimal chaperonin systems based on CCT4 homo-oligomers

  • Creating orthogonal folding systems for synthetic circuits

What emerging technologies might enhance our understanding of CCT4 function in the future?

Emerging technologies with potential impact include:

• Cryo-electron tomography:

  • Visualize TRiC complexes in their native cellular environment

  • Identify spatial organization and interactions with other cellular components

• AlphaFold and other AI-based structure prediction:

  • Model dynamic conformational changes

  • Predict substrate interactions

  • Design novel mutations for functional studies

• Time-resolved cryo-EM:

  • Capture short-lived conformational states during the folding cycle

  • Elucidate the dynamics of ATP-driven conformational changes

• Proximity labeling techniques:

  • Map the dynamic interactome of CCT4 in different cellular states

  • Identify transient interactions with substrates and co-factors

• Gene editing combined with high-throughput phenotyping:

  • Systematic mutagenesis to identify critical residues

  • Link sequence variants to functional outcomes

These technologies promise to reveal new aspects of CCT4 function and its integration into cellular processes.